U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07145190) titled 'SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment' on Aug. 21.
Brief Summary: The purpose of the study is to generate real-world evidence data for the on-demand treatment with SL-APO, focusing on understanding its usage and titration practices including individual dose determination after dose-adjustment to ultimately understand their influence in patient satisfaction, treatment persistence, and the balance between effectiveness and safety. The data may help optimize titration approaches to better meet the patient's needs.
Study Start Date: Aug. 27
Study Type: OBSERVATIONAL
Condition:
Parkinson Disea...